6 SMALL MOLECULE MARKET DYNAMICS 6 Overview 6 Key trends 8 Market drivers and restraints 12 References
14 CMO AND SPONSOR STRATEGIES 14 Preferred partner arrangements 17 Deal activity will focus on technologies and geographical markets 19 Emerging markets are increasingly important 20 References LIST OF FIGURES Figure 1: Comparison of the capabilities of the 10 leading small molecule CMOs
LIST OF TABLES Table 1: Major M&A deals in the CMO sector, 2010–12
Figure 1: Comparison of the capabilities of the 10 leading small molecule CMOs
This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.